Bob Dylan sued for alleged sexual abuse of 12-year-old in 1960s

FAN Editor
United States music legend Bob Dylan sits on stage before receiving his honorary Doctor of Music degree during a ceremony at St Andrews University
FILE PHOTO: United States music legend Bob Dylan sits on stage before receiving his honorary Doctor of Music degree during a ceremony at St Andrews University, Scotland, June 23, 2004. REUTERS/David Cheskin/POOL

August 17, 2021

(Reuters) – An unnamed woman has sued folk singer-songwriter Bob Dylan alleging he sexually abused her after giving her drugs and alcohol in 1965 when she was 12 years old.

A spokesman for Dylan, now 80, said the allegations were false. “The 56-year-old claim is untrue and will be vigorously defended,” the spokesman said. 

In a civil lawsuit filed late on Friday with the New York Supreme Court, the woman identified only as J.C. said Dylan sexually abused her at his New York apartment over a six-week period “leaving her emotionally scarred and psychologically damaged to this day.”

Dylan, who was in his mid-20s at the time, “exploited his status as a musician to provide J.C. with alcohol and drugs and sexually abuse her multiple times,” the lawsuit said.

The plaintiff is seeking unspecified damages. Her lawsuit was submitted just ahead of a New York state deadline, authorized in a 2019 law, for people to file legal claims involving allegations of sexual abuse of children that in the past were too old to pursue due to a statute of limitations.

Dylan emerged from the Greenwich Village folk scene in the early 1960s to become one of the most acclaimed and influential artists of the rock era with hits including “Blowin’ in the Wind” and “Like a Rolling Stone.”

He has sold more than 125 million records globally and won the Nobel prize for literature in 2016.

(Reporting by Lisa Richwine; Editing by Stephen Coates)

Free America Network Articles

Leave a Reply

Next Post

Pfizer submits data to FDA for authorization of Covid vaccine booster shot for general population

Pfizer and BioNTech said Monday they have submitted early stage clinical trial data to the Food and Drug Administration as part of their U.S. application seeking authorization of a Covid vaccine booster for everyone 16 and older — not just people with weak immune systems. In a phase one trial, […]

You May Like